unknown
Stage
About
AbInitio Bio develops foundation AI models for biomanufacturing that are validated against wet lab data; its first model, Echo, predicts manufacturing outcomes and can be adapted by pharmaceutical companies and CDMOs to accelerate process decisions.
Explore AbInitio Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.